3/10
12:34 pm
wve
WAVE Life Sciences (WVE) had its price target raised by Canaccord Genuity Group Inc. from $43.00 to $52.00. They now have a "buy" rating on the stock.
Low
Report
WAVE Life Sciences (WVE) had its price target raised by Canaccord Genuity Group Inc. from $43.00 to $52.00. They now have a "buy" rating on the stock.
3/6
09:17 am
wve
WAVE Life Sciences (WVE) had its price target raised by Wedbush from $33.00 to $35.00. They now have an "outperform" rating on the stock.
Low
Report
WAVE Life Sciences (WVE) had its price target raised by Wedbush from $33.00 to $35.00. They now have an "outperform" rating on the stock.
3/5
09:01 am
wve
Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference [Yahoo! Finance]
Medium
Report
Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference [Yahoo! Finance]
3/5
08:30 am
wve
Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference
Low
Report
Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference
3/2
08:03 am
wve
WAVE Life Sciences (WVE) had its "buy" rating reaffirmed by HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
WAVE Life Sciences (WVE) had its "buy" rating reaffirmed by HC Wainwright. They now have a $30.00 price target on the stock.
3/2
07:19 am
wve
Wave Life Sciences Teases Near-Term Obesity and RNA Editing Data as INLIGHT Readouts Near [Yahoo! Finance]
Low
Report
Wave Life Sciences Teases Near-Term Obesity and RNA Editing Data as INLIGHT Readouts Near [Yahoo! Finance]
2/28
01:40 pm
wve
Wave Life Sciences Ltd. (WVE): A Bull Case Theory [Yahoo! Finance]
Low
Report
Wave Life Sciences Ltd. (WVE): A Bull Case Theory [Yahoo! Finance]
2/28
04:59 am
wve
Wave Life Sciences Ltd. (WVE) Announces Fiscal Q4 and Full-Year 2025 Earnings [Yahoo! Finance]
Low
Report
Wave Life Sciences Ltd. (WVE) Announces Fiscal Q4 and Full-Year 2025 Earnings [Yahoo! Finance]
2/26
08:13 am
wve
Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
2/26
07:30 am
wve
Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Medium
Report
Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2/23
09:10 am
wve
Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Low
Report
Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
2/23
08:30 am
wve
Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Low
Report
Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
2/23
06:43 am
wve
Wave Life Sciences (WVE) Valuation Check After Regaining WVE-006 Rights And New Buy Analyst Coverage [Yahoo! Finance]
Low
Report
Wave Life Sciences (WVE) Valuation Check After Regaining WVE-006 Rights And New Buy Analyst Coverage [Yahoo! Finance]
2/19
08:30 am
wve
Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026
Low
Report
Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026
2/16
12:38 pm
wve
Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program [Yahoo! Finance]
Medium
Report
Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program [Yahoo! Finance]
2/12
09:46 am
wve
WAVE Life Sciences (NASDAQ:WVE) had its price target lowered by analysts at Wells Fargo & Company from $29.00 to $27.00. They now have an "overweight" rating on the stock.
Low
Report
WAVE Life Sciences (NASDAQ:WVE) had its price target lowered by analysts at Wells Fargo & Company from $29.00 to $27.00. They now have an "overweight" rating on the stock.
2/9
12:02 am
wve
The Bull Case For Wave Life Sciences (WVE) Could Change Following WVE-006 Rights Reversion And FDA Talks [Yahoo! Finance]
Low
Report
The Bull Case For Wave Life Sciences (WVE) Could Change Following WVE-006 Rights Reversion And FDA Talks [Yahoo! Finance]
2/8
05:36 pm
wve
Assessing Wave Life Sciences (WVE) Valuation After A 7x Three Year Total Return [Yahoo! Finance]
Low
Report
Assessing Wave Life Sciences (WVE) Valuation After A 7x Three Year Total Return [Yahoo! Finance]
2/7
03:48 am
wve
Wave Life Sciences (WVE) Regains Rights to Potential Rare Genetic Disorder Treatment [Yahoo! Finance]
Low
Report
Wave Life Sciences (WVE) Regains Rights to Potential Rare Genetic Disorder Treatment [Yahoo! Finance]
2/7
02:07 am
wve
WAVE Life Sciences (NASDAQ:WVE) was downgraded by analysts at
Wall Street
Low
Report
WAVE Life Sciences (NASDAQ:WVE) was downgraded by analysts at
Wall Street
2/5
10:00 am
wve
WAVE Life Sciences (NASDAQ:WVE) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $38.00 price target on the stock.
High
Report
WAVE Life Sciences (NASDAQ:WVE) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $38.00 price target on the stock.
2/5
09:41 am
wve
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Cantor Fitzgerald from $34.00 to $41.00. They now have an "overweight" rating on the stock.
Medium
Report
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Cantor Fitzgerald from $34.00 to $41.00. They now have an "overweight" rating on the stock.
2/3
12:51 pm
wve
Wave Life Sciences price target raised to $50 from $47 at Clear Street [Yahoo! Finance]
Low
Report
Wave Life Sciences price target raised to $50 from $47 at Clear Street [Yahoo! Finance]
2/3
08:15 am
wve
WAVE Life Sciences (NASDAQ:WVE) was given a new $43.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
WAVE Life Sciences (NASDAQ:WVE) was given a new $43.00 price target on by analysts at Canaccord Genuity Group Inc..
2/2
07:41 am
wve
Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency [Yahoo! Finance]
Medium
Report
Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency [Yahoo! Finance]